Overview

Description

  • NatureSynthetic
  • Amino Acid Sequence
    • SpeciesHuman
    • SequenceC-YGQPSTKHYVTS
    • Amino acids540 to 551

Associated products

Specifications

Our Abpromise guarantee covers the use of ab23022 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking - Blocking peptide for Anti-GERP antibody (ab4302)

  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

General Info

  • Alternative names
    • AA408830
    • BB006755
    • Glioblastoma-expressed RING finger protein
    • Lioblastoma expressed ring finger protein
    • Probable E3 ubiquitin-protein ligase TRIM8
    • RING finger protein 27
    • RNF27
    • RP11-47A8.4
    • TRIM8
    • TRIM8_HUMAN
    • Tripartite motif containing 8
    • Tripartite motif protein TRIM8
    • Tripartite motif-containing protein 8
    see all
  • FunctionProbable E3 ubiquitin-protein ligase which may promote proteasomal degradation of SOCS1.
  • Tissue specificityWidely expressed.
  • PathwayProtein modification; protein ubiquitination.
  • Sequence similaritiesBelongs to the TRIM/RBCC family.
    Contains 2 B box-type zinc fingers.
    Contains 1 RING-type zinc finger.
  • DomainThe coiled coil domain is required for homodimerization.
    The region immediately C-terminal to the RING motif is sufficient to mediate the interaction with SOCS1.
  • Information by UniProt

References for Human GERP peptide (ab23022)

ab23022 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab23022.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"